Gilead Sciences, Inc. (GILD) Financials

GILD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 56.3 billion 32.8 billion
Dec. 31, 2025 59.0 billion 36.4 billion
Sept. 30, 2025 58.5 billion 37.1 billion
June 30, 2025 55.7 billion 36.1 billion

GILD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.4 billion ?
Dec. 31, 2025 3.1 billion 230.0 million
Sept. 30, 2025 4.0 billion 230.0 million
June 30, 2025 720.0 million 225.0 million

GILD Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 2.0 billion
Dec. 31, 2025 2.2 billion
Sept. 30, 2025 3.1 billion
June 30, 2025 2.0 billion

GILD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 9.8 billion 20.9 billion -
Dec. 31, 2025 10.6 billion 24.6 billion -
Sept. 30, 2025 7.3 billion 22.1 billion -
June 30, 2025 5.2 billion 22.1 billion -

GILD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 1.3 billion
Dec. 31, 2025 1.3 billion
Sept. 30, 2025 1.3 billion
June 30, 2025 1.3 billion

GILD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 117.0 million 1.4 billion 1.5 billion -
Dec. 31, 2025 205.0 million 1.6 billion 1.7 billion 1.1 billion
Sept. 30, 2025 147.0 million 1.3 billion 1.4 billion 829.0 million
June 30, 2025 107.0 million 1.5 billion 1.4 billion 864.0 million

GILD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 7.0 billion 1.4 billion
Dec. 31, 2025 7.9 billion 1.6 billion
Sept. 30, 2025 7.8 billion 1.6 billion
June 30, 2025 7.1 billion 1.5 billion

GILD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GILD

List: Contenders

Price: $128.99

52 week price:
104.46
157.29

Dividend Yield: 2.47%

5-year range yield:
2.14%
5.18%

Forward Dividend Yield: 2.54%

Payout Ratio: 375.61%

Payout Ratio Range:
-69.01%
24533.33%

Dividend Per Share: 3.19 USD

Earnings Per Share: 7.34 USD

P/E Ratio: 18.13

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.7 million

Ebitda: 2.4 billion

Market Capitalization: 160.2 billion

Average Dividend Frequency: 4

Years Paying Dividends: 12

DGR3: 2.70%

DGR5: 3.56%

DGR10: 30.00%

Links: